Editor's note: In order to better standardize the clinical rational diagnosis and treatment of HER2-positive breast cancer and achieve "suitable population, reasonable timing, and appropriate plan", the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology an - DayDayNews regimen

Editor's note: In order to better standardize the clinical rational diagnosis and treatment of HER2-positive breast cancer and achieve "suitable population, reasonable timing, and appropriate plan", the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology an

CSCO Special Invitation | Professor Jiang Zefei: Highlight interpretation of the 2023 edition of "Expert Consensus on the Diagnosis and Treatment of Targeted HER2 Breast Cancer" - The future of accurate diagnosis and treatment of HER2 breast cancer is promising